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values across all four responsiveness measures. Findings were similar in the 
subgroup of patients with high storage symptoms at baseline. CONCLUSIONS: 
This large study provided a comprehensive examination of the measurement 
properties of the PPIUS. The TUFS provided an excellent combination of 
measurement properties and is therefore considered one of the most appropriate 
PPIUS endpoint for use in studies of patients with LUTS associated with BPH.  
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OBJECTIVES: To understand how individuals value information from diagnostic 
technologies, we reviewed and analyzed published willingness-to-pay (WTP) 
studies on the topic. METHODS: We searched PubMed for English-language 
articles related to the WTP for diagnostic laboratory tests published from 1985 
through 2011. We characterized methodological differences across studies, 
examined individual- and technology-level factors associated with WTP, and 
summarized median WTP values across different diagnostic tests. RESULTS: We 
identified 66 relevant WTP studies. Half focused on oncology, while the 
remainder analyzed infectious diseases (16.1%) and obstetric or gynecological 
conditions (11.7%) among other areas. Most laboratory tests investigated in 
studies were biological samples/genetic testing (61.1%) or imaging tests (31.9%). 
Roughly one-third of the analyses (30.3%) used discrete-choice questions to elicit 
WTP, while others used payment cards (15.2%) and bidding games (13.6%). Of the 
44 studies with median WTP values available, most reported values below $100, 
though there was substantial variation in some technologies (e.g., median WTP 
for colon or colorectal cancer screening ranged from below $100 to over $1,000). 
Patient factors associated with higher WTP for diagnostic information included 
higher income, education, disease severity, perceived disease risk, and family 
history. More severe conditions and diseases without a controllable risk factor, 
such as some cancers and congenital abnormalities, were associated with higher 
WTP estimates. More accurate tests appeared to have higher WTP. 
CONCLUSIONS: The contingent valuation literature in diagnostics has grown 
rapidly, and suggests that respondents may place considerable value on 
diagnostic information. However, there exists great variation in studies with 
respect to the type of technologies and diseases assessed, respondent 
characteristics, and methodology used. The perceived value of diagnostic 
technologies is also influenced by the study design and elicitation methods.  
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OBJECTIVES: To summarize the magnitude of placebo effects on patient-
reported physical and mental health outcomes in well-controlled drug trials. 
METHODS: We conducted a systematic review of randomized, double-blind, 
placebo-controlled drug trials via PubMed and supplemental sources published 
over a 12-year period (1/1/1995-12/31/2011) with documentation of full Medical 
Outcomes Study short-form 36 (SF-36) scores by treatment group. Standardized 
effects (SE=change/general population SD) for SF-36 physical and mental 
component summary score (PCS, MCS) changes were computed from baseline to 
endpoint for each treatment arm. SE was evaluated versus Cohen’s dcutoffs 
(small ≤0.30, medium 0.30 to 0.80, and large SE ≥0.80), as well as currently 
recommended minimum important difference (MID) thresholds of 0.3 and 0.5 SD 
units. RESULTS: The search identified 805 publications, 150 of which were well-
controlled and sufficiently documented drug trials for 35 heterogeneous medical 
conditions. Sample sizes varied with IQR: 67-448 (median= 205). The majority  
of trials, 107 (71.3%) reported small SE for PCS or MCS. Medium placebo effects 
were reported in 37 trials (25%). Large SE were reported in just 6(4%) trials.  
In contrast, clinically effective drug treatment arm effects were more often 
medium (51/103;50%) and large(19/104;18%). Median SE for placebo arms across 
all trials for PCS was 0.11(IQR: 0.00 to 0.26), for MCS (median=0.06, IQR: -0.05 to 
0.21). Mean placebo changes met the 0.3 MID threshold in 43 (29%) trials; 17(12%) 
met the 0.5 point threshold. CONCLUSIONS: Although placebo effects are most 
often small for patient-reported physical and mental outcomes, a noteworthy 
proportion of well-controlled trials report placebo effects achieving the 0.3 SD 
MID threshold. Therefore, we recommend evaluating MID for single group 
comparisons (of controlled or observational data), with a 0.5 SD cutoff, and for 
controlled trial findings expressed as net of placebo changes, with a smaller 0.3 
SD cutoff.  
 
PRM139  
BARRIERS TO FOLLOW UP CARE IN CHILDREN WITH VISION DISEASES: 
DEVELOPMENT OF A CONCEPTUAL FRAMEWORK AND PARENT/ 
CAREGIVER SURVEY THROUGH THE CHILDREN'S EYE CARE ADHERENCE 
PROJECT  
Levin AV1, Pizzi LT2, Snitzer M1, Prioli KM2 
1Wills Eye Institute, Philadelphia, PA, USA, 2Thomas Jefferson University, Philadelphia, PA, USA  
OBJECTIVES: The follow-up rate of socioeconomically at risk children with vision 
diseases is only 5% at our eye institution. Through the Children’s Eyecare 
Adherence Project (CECAP), we identified barriers to care in this population and 
developed a conceptual framework as well as parent/caregiver questionnaire. 
METHODS: Barriers to follow-up were obtained by two trained medical students 
who phoned parents/caregivers of high-risk Philadelphia schoolchildren 
identified in 2010-2011 as having eye problems requiring a follow up visit within 
1 year through our mobile outreach van and annual Give Kids Sight Day exams. 
Barriers were then organized into a conceptual framework depicting main 
themes and inter-relationships. RESULTS: Ninety-three parents/caregivers were 
phoned with ten barriers to follow-up identified and organized into 3 main 
themes: 1) predisposing factors (lack of awareness, perceived importance, 
conflict of commitment, lack of communication means); 2) system factors (lack 
of referral, clinical scheduling difficulty, lack of transportation access); 3) 
financial factors (lack of insurance, health care payment difficulty, 
transportation payment difficulty). A 13-item (12 dichotomous, 1 open-ended) 
questionnaire was developed encompassing these 10 barriers for administration 
to parents/caregivers. CONCLUSIONS: The resulting CECAP parent/caregiver 
survey is brief and of use for future patient support and outreach programs of 
children with vision diseases. Ongoing work involves validating this survey 
through a larger study of children identified in 2012 as needing follow up.  
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OBJECTIVES: The common international standard for measuring health benefit 
within economic evaluation requires the use of generic preference-based health-
related quality of life (HRQoL) instruments. The availability of multiple 
instruments raises questions about their relative merits and recent studies have 
highlighted the paucity of evidence regarding measurement properties in the 
context of spinal cord injury (SCI). As part of a mixed-methods research 
program, this qualitative study explores the appropriateness of 6 established 
instruments for use in SCI populations. METHODS: Individuals living with SCI 
were invited to participate in one of three focus groups (n=15). Eligible 
participants were identified from Vancouver General Hospital’s Spine Program 
database; purposive sampling was used to ensure that a range of demographic 
and injury-related characteristics were represented. Perceptions and opinions 
were solicited on the following questionnaires: 15D, Assessment of Quality of 
Life (AQoL-8D), EQ-5D-5L, Health Utilities Index, self-administered Quality of 
Well-Being Scale, and SF-36v2. Framework Analysis was used to evaluate the 
qualitative information gathered during discussion. Strengths and limitations of 
each questionnaire were thematically identified and managed using NVivo 
software. RESULTS: Major emergent themes were (i) general perceptions, (ii) 
comprehensiveness, (iii) content, (iv) wording, and (v) features. Two sub-themes 
pertinent to content were also identified; ‘questions’ and ‘options’. All focus 
group participants perceived the AQoL-8D to be the most relevant instrument to 
administer to an SCI population. This measure was widely considered to be 
comprehensive, with relevant content (i.e. wheelchair inclusive) and applicable 
items. Participants had mixed perceptions about the other 5 questionnaires, 
albeit to varying degrees. CONCLUSIONS: The 35-item AQoL-8D was consistently 
viewed as the most appropriate preference-based HRQoL instrument for 
individuals living with SCI. Despite a strong theoretical underpinning, AQoL 
instruments are infrequently used in North America and further empirical 
research is necessary to build on these encouraging qualitative findings.  
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OBJECTIVES: The objective of this study is to quantify utilities loss in men and 
women affected by HPV-induced pathologies in Italy. METHODS: A multicentre, 
retrospective study was designed to enroll a cohort of males and females with 
HPV-related diseases who were detected and managed in the preceding 18 
months. Utilities were calculated using the Time Trade-Off (TTO) method. The 
elicitation of utilities was performed using a validated algorithm [Mennini et al. 
Clin Ther 2011 ] specifically developed to the computer-guided and standardized 
administration of a TTO questionnaire. Utilities associated with each of the 
following pathologies were assessed: atypical squamous cells of undetermined 
significance (ASCUS), cervical intraepithelial neoplasia (CIN) grade 1, CIN grade 
2-3 and cervical cancer in women; anogenital warts, anal cancer and head and 
neck cancer both in men and women. The European Quality of Life questionnaire 
(EQ-5D) was used to assess the baseline health conditions of respondents. 
RESULTS: On 450 enrolled patients, 421 (mean age 44.9±16.5 years) responded, 
providing an overall response rate of 93.6%. The patients’ perception of their 
health state was rather high (EQ-5D score ranged between 1 and 0.8), with the 
exception of patients affected by anal cancer patients (EQ-5D corresponding to 
0.6±0.3). The mean utility value by HPV-induced pathology corresponded to 
0.77±0.27, 0.71±0.29, 0.83±0.22, 0.81±0.27, 0.58±0.31, 0.51±0.26 and 0.69±0.30 for 
ASCUS, CIN1, CIN2-3, invasive cervical cancer, anogenital warts, anal cancer and 
head and neck cancer, respectively. The regression analysis showed that only 
the pathological condition influences the estimated utility value. CONCLUSIONS: 
Patients' health-state preference is a variable with a high impact on economic 
evaluations. The measurement of each utility relied on a solid and well 
recognized procedure. This multicenter study elicited utilities in a wide range of 
HPV-induced pathologies and in a large sample size as well.  
